Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA budget

This article was originally published in The Tan Sheet

Executive Summary

The final fiscal year 2007 enacted budget for FDA is $1.57 bil., according to a recent FDA announcement. The amount represents an increase of $84 mil. over the full-year continuing resolution reported for FY 2007 in the president's FY 2008 budget request. The new funding level includes increases to food defense, which was awarded an additional $14 mil., and drug safety, which was awarded an additional $6 mil. The Office of Women's Health was awarded $4 mil., which represents an increase over the FY 2006 amount of $3.96 mil. Rep. Rosa DeLauro, D-Conn., recently introduced legislation to protect OWH funding (1"The Tan Sheet" March 5, 2007, p. 19)...

You may also be interested in...

Bill Would Require Plan B Workshop, Elevate FDA’s Office Of Women’s Health

A House Judiciary subcommittee chair will reintroduce a bill that would require FDA to conduct a scientific workshop to examine data on the use of Barr's Plan B emergency contraceptive in women under age 18

Big Pharma BD Execs Tell Start-Ups: Don’t Be Afraid To Ask Us For Help

Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.

Transformation Into Viatris Not Seen As The Solution Mylan Needs

Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts